beijing hotgen biotech co.,ltd (688068.SH) released the third quarter report for 2024, with a revenue of 3....
Zhixin Finance APP News, Beijing Hotgen Biotech Co., Ltd. (688068.SH) released the third quarter report for 2024, with a revenue of 0.386 billion yuan, a year-on-year decrease of 5.10%; the net loss attributable to shareholders of the listed company was 40.6386 million yuan; the net loss after deducting non-recurring gains and losses attributable to shareholders of the listed company was 0.102 billion yuan; basic loss per share was 0.44 yuan/share.